Symbol Name ID |
Tbc1d10c
TBC1 domain family, member 10c MGI:1922072 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou Cd79atm1(cre)Reth/Cd79a+ involves: 129S2/SvPas * BALB/c * C57BL/6J |
abnormal B cell physiology | J:211913 |
increased anti-double stranded DNA antibody level | J:211913 | |
increased IgG level | J:211913 | |
increased IgM level | J:211913 | |
increased susceptibility to systemic lupus erythematosus | J:211913 | |
Tbc1d10ctm1.1Psou/Tbc1d10ctm1.2Psou Tg(Lck-cre)#Nik/0 involves: 129S2/SvPas * C57BL/6 * C57BL/6J * DBA/2 |
normal immune system phenotype | J:211913 |
Tbc1d10ctm1.2Psou/Tbc1d10ctm1.2Psou involves: 129S2/SvPas * C57BL/6J |
abnormal B cell physiology | J:211913 |
abnormal response to infection | J:211913 | |
abnormal T cell activation | J:211913 | |
normal immune system phenotype | J:211913 | |
increased anti-double stranded DNA antibody level | J:211913 | |
increased IgG level | J:211913 | |
increased susceptibility to systemic lupus erythematosus | J:211913 | |
increased T cell proliferation | J:211913 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 08/02/2024 MGI 6.24 |
![]() |
|